Literature DB >> 17305586

Breath analysis: the approach towards clinical applications.

Anton Amann1, Patrik Spanĕl, David Smith.   

Abstract

Exhaled breath analysis for clinical diagnosis and therapeutic monitoring is described with special reference to the techniques used and the underlying chemistry and physics involved. Brief outlines are given of the research carried out to date, and prospects for the future of this potentially valuable non-invasive technique are indicated.

Mesh：

Substances：

Year:  2007        PMID： 17305586     DOI： 10.2174/138955707779802606

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN： 1389-5575            Impact factor:   3.862


  35 in total

1.  A mathematical model for breath gas analysis of volatile organic compounds with special emphasis on acetone.

Authors:  Julian King; Karl Unterkofler; Gerald Teschl; Susanne Teschl; Helin Koc; Hartmann Hinterhuber; Anton Amann
Journal:  J Math Biol       Date:  2011-01-14       Impact factor: 2.259

Review 2.  The state of molecular biomarkers for the early detection of lung cancer.

Authors:  Mohamed Hassanein; J Clay Callison; Carol Callaway-Lane; Melinda C Aldrich; Eric L Grogan; Pierre P Massion
Journal:  Cancer Prev Res (Phila)       Date:  2012-06-11

3.  Volatile organic compound analysis by ion molecule reaction mass spectrometry for Gram-positive bacteria differentiation.

Authors:  M E Dolch; C Hornuss; C Klocke; S Praun; J Villinger; W Denzer; G Schelling; S Schubert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-11       Impact factor: 3.267

4.  Noninvasive detection of lung cancer by analysis of exhaled breath.

Authors:  Amel Bajtarevic; Clemens Ager; Martin Pienz; Martin Klieber; Konrad Schwarz; Magdalena Ligor; Tomasz Ligor; Wojciech Filipiak; Hubert Denz; Michael Fiegl; Wolfgang Hilbe; Wolfgang Weiss; Peter Lukas; Herbert Jamnig; Martin Hackl; Alfred Haidenberger; Bogusław Buszewski; Wolfram Miekisch; Jochen Schubert; Anton Amann
Journal:  BMC Cancer       Date:  2009-09-29       Impact factor: 4.430

5.  Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors.

Authors:  G Peng; M Hakim; Y Y Broza; S Billan; R Abdah-Bortnyak; A Kuten; U Tisch; H Haick
Journal:  Br J Cancer       Date:  2010-07-20       Impact factor: 7.640

Review 6.  Carbon monoxide in exhaled breath testing and therapeutics.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  J Breath Res       Date:  2013-02-27       Impact factor: 3.262

7.  Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticles.

Authors:  Orna Barash; Nir Peled; Fred R Hirsch; Hossam Haick
Journal:  Small       Date:  2009-11       Impact factor: 13.281

8.  Detection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors.

Authors:  Ulrike Tisch; Yuval Aluf; Radu Ionescu; Morad Nakhleh; Rana Bassal; Noa Axelrod; Dorina Robertman; Yael Tessler; John P M Finberg; Hossam Haick
Journal:  ACS Chem Neurosci       Date:  2011-12-19       Impact factor: 4.418

9.  Diagnosing lung cancer in exhaled breath using gold nanoparticles.

Authors:  Gang Peng; Ulrike Tisch; Orna Adams; Meggie Hakim; Nisrean Shehada; Yoav Y Broza; Salem Billan; Roxolyana Abdah-Bortnyak; Abraham Kuten; Hossam Haick
Journal:  Nat Nanotechnol       Date:  2009-08-30       Impact factor: 39.213

10.  Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro.

Authors:  Wojciech Filipiak; Andreas Sponring; Tomas Mikoviny; Clemens Ager; Jochen Schubert; Wolfram Miekisch; Anton Amann; Jakob Troppmair
Journal:  Cancer Cell Int       Date:  2008-11-24       Impact factor: 5.722
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.